← Back to Search

System Dynamics vs Quality Improvement for Mental Health Care

N/A
Waitlist Available
Led By Lindsey E. Zimmerman, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-/post- 12-month period average of ebp reach (24 months total observation)]
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to increase the proportion of patients who start and complete evidence-based care using participatory system dynamics, and to determine the costs of using this method.

Who is the study for?
This trial is for VA divisions and outpatient clinics that are performing below the median in mental health care quality, specifically for depression, PTSD, and opioid use disorder. Clinics must have a multidisciplinary team but can't be part of certain other QI programs or planning to implement a new EHR system during the study.
What is being tested?
The trial compares Participatory System Dynamics (PSD), which uses simulations to help staff make better decisions about resource allocation and scheduling, with usual quality improvement methods. It aims to see if PSD can increase patient access to evidence-based mental health care more effectively.
What are the potential side effects?
Since this intervention involves organizational strategies rather than medical treatments, traditional side effects aren't applicable. However, there may be indirect impacts on staff workload or workflow changes as they adapt to new systems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-/post- 12-month period average of ebp reach (24 months total observation)]
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-/post- 12-month period average of ebp reach (24 months total observation)] for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of combination of prescriptions placed with the VA pharmacy and sessions with a relevant CPT code
Number of completed EBPsy templates during sessions with a relevant CPT code
Proportion of patients initiating and completing a course of evidence-based psychotherapy (EBPsy) or evidence-based pharmacotherapy (EBPharm)
Secondary study objectives
Demographic Measures
Differences in team perceptions of MTL and QI assessed by the Acceptability of Intervention Measure (AIM)
Differences in team perceptions of MTL and QI assessed by the Feasibility of Intervention Measure (FIM)
+11 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual quality improvement (QI)Experimental Treatment1 Intervention
12 clinics randomly assigned to usual QI
Group II: Modeling to Learn (MTL)Experimental Treatment1 Intervention
12 clinics randomly assigned to MTL

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,084 Total Patients Enrolled
78 Trials studying Depression
19,254 Patients Enrolled for Depression
Lindsey E. Zimmerman, PhDPrincipal InvestigatorVA Palo Alto Health Care System, Palo Alto, CA

Media Library

Modeling to Learn (MTL) Clinical Trial Eligibility Overview. Trial Name: NCT04208217 — N/A
Depression Research Study Groups: Modeling to Learn (MTL), Usual quality improvement (QI)
Depression Clinical Trial 2023: Modeling to Learn (MTL) Highlights & Side Effects. Trial Name: NCT04208217 — N/A
Modeling to Learn (MTL) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04208217 — N/A
~18 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top